drugset / Trial / NCT05370716

Drug-Drug Interaction Study of "CG-651" in Healthy Volunteer

NCT05370716

Phase 1 Completed 47 enrolled CrystalGenomics, Inc.
RandomizedParallel-groupOpen-labelTreatment

Summary

This is randomized , open-label, multiple-dose, parallel study to compare the pharmacokinetics and to evaluate Drug-Drug Interaction of "CG-651" in healthy volunteers.

Timeline

Start
2019-11-11
Primary completion
2020-04-30
Completion
2020-05-19

Drugs

EvaluationDrugModalityDoseRoute
Subject Polmacoxib Other / unclassified
Subject Pregabalin Small molecule

Indications

No indication recorded.